These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 26250653

  • 1. P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain.
    Choi JY, Song JS, Lee M, Cho WK, Chung J, Lyoo CH, Kim CH, Park J, Lee KC, Kim KM, Kang JH, Bae MA, Ryu YH.
    Mol Imaging Biol; 2016 Apr; 18(2):267-73. PubMed ID: 26250653
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor.
    Bauer F, Kuntner C, Bankstahl JP, Wanek T, Bankstahl M, Stanek J, Mairinger S, Dörner B, Löscher W, Müller M, Erker T, Langer O.
    Bioorg Med Chem; 2010 Aug 01; 18(15):5489-97. PubMed ID: 20621487
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
    Bihorel S, Camenisch G, Lemaire M, Scherrmann JM.
    J Neurochem; 2007 Sep 01; 102(6):1749-1757. PubMed ID: 17696988
    [Abstract] [Full Text] [Related]

  • 9. A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier.
    Wanek T, Kuntner C, Bankstahl JP, Mairinger S, Bankstahl M, Stanek J, Sauberer M, Filip T, Erker T, Müller M, Löscher W, Langer O.
    J Cereb Blood Flow Metab; 2012 Nov 01; 32(11):2002-11. PubMed ID: 22828996
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract.
    Robillard KR, Chan GN, Zhang G, la Porte C, Cameron W, Bendayan R.
    Antimicrob Agents Chemother; 2014 Nov 01; 58(3):1713-22. PubMed ID: 24379203
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of P-glycoprotein (abcb1a/b) modulation of [(18)F]fallypride in MicroPET imaging studies.
    Piel M, Schmitt U, Bausbacher N, Buchholz HG, Gründer G, Hiemke C, Rösch F.
    Neuropharmacology; 2014 Sep 01; 84():152-8. PubMed ID: 23994301
    [Abstract] [Full Text] [Related]

  • 16. The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice.
    Zhou L, Schmidt K, Nelson FR, Zelesky V, Troutman MD, Feng B.
    Drug Metab Dispos; 2009 May 01; 37(5):946-55. PubMed ID: 19225039
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by P-Glycoprotein and Breast Cancer Resistance Protein Efflux Transporters in Mice.
    Ganguly S, Panetta JC, Roberts JK, Schuetz EG.
    Drug Metab Dispos; 2018 Jul 01; 46(7):1014-1022. PubMed ID: 29674491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.